BAF250a, also known by its gene name ARID1A, is a pivotal component of the SWI/SNF chromatin remodeling complex that plays a critical role in regulating gene expression by altering the chromatin structure. As a part of this complex, BAF250a facilitates access to DNA for transcription factors and, as a result, is integral to the transcriptional activation of various genes. The expression of BAF250a itself is subject to sophisticated control by a network of signaling pathways that reflect the cell's physiological state. In understanding the regulation of BAF250a, researchers have pinpointed a range of chemical compounds that can potentially upregulate the expression of this protein, shedding light on the intricate mechanics of gene regulation. These chemicals, often through epigenetic modifications or signaling cascades, can induce a more transcriptionally permissive environment around the ARID1A gene, thereby boosting BAF250a levels.
Among the chemicals that have been hypothesized to induce BAF250a expression are epigenetic modifiers like 5-Aza-2'-deoxycytidine and Trichostatin A, which target DNA methylation and histone acetylation, respectively. These compounds are thought to enhance the transcription of BAF250a by altering the chromatin landscape at the gene's promoter region, making it more accessible for transcriptional machinery. Other compounds, such as Forskolin and Sulforaphane, are believed to upregulate BAF250a through the activation of cellular signaling pathways that respond to environmental stimuli. Forskolin, for example, increases intracellular cAMP levels, which can lead to the activation of protein kinase A (PKA) and subsequent phosphorylation of transcription factors that drive BAF250a transcription. Similarly, Sulforaphane has been observed to stimulate antioxidant response elements that could enhance BAF250a expression as part of a cellular defensive mechanism. Compounds like Vitamin D3 and retinoic acid, which function as ligands for nuclear hormone receptors, also have the potential to upregulate BAF250a by binding to their respective receptors and modulating gene expression patterns, including those within the ARID1A locus. The diversity of these chemicals highlights the complex regulatory network that governs the expression of BAF250a and underscores the importance of broad-based approaches to study gene expression regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This compound could induce demethylation of the ARID1A gene promoter, which may lead to the transcriptional activation and subsequent increase in BAF250a expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
By inhibiting histone deacetylases, Trichostatin A may promote acetylation of histones at the ARID1A locus, which could stimulate the transcription and upregulate BAF250a. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane may activate antioxidant response elements within the ARID1A gene promoter, potentially triggering an enhancement in BAF250a transcription. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
This compound may interact with retinoic acid receptors to initiate a transcriptional cascade that specifically targets the ARID1A gene, leading to an upsurge in BAF250a levels. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
By elevating intracellular cAMP, Forskolin could activate a signaling cascade culminating in the enhanced expression of BAF250a. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
This secosteroid may engage the vitamin D receptor, resulting in a transcriptional response that includes the upregulation of BAF250a. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin could exert its effect by upregulating transcription factors or enhancers associated with the ARID1A gene, leading to an increase in BAF250a synthesis. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol may stimulate the expression of BAF250a through the activation of SIRT1, leading to changes in promoter accessibility and gene transcription enhancement. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This green tea polyphenol may induce epigenetic alterations that result in the transcriptional activation of the ARID1A gene and an increased production of BAF250a. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin could stimulate AMPK, leading to a downstream transcriptional response that includes the upregulation of BAF250a expression. | ||||||